Viewing Study NCT06584006


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2026-03-09 @ 4:09 AM
Study NCT ID: NCT06584006
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Sponsor: The First Affiliated Hospital of Xiamen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Malignancy View
None Lymphocytopenia View
Keywords: